Blogs | Multibagger Shares

April 4, 2026

The Debt-Free Balance Sheet Superpower

📅 Published April 4, 2026 (Saturday) 🏰 Today’s Fundamental Analysis Lesson: The Debt-Free Balance Sheet Superpower SEBI’s landmark study revealed that 9 out of 10 individual […]

April 4, 2026

Infographic Risk adjusted Returns with a Stacked Bar Chart Showing Fy20fy25 Values Ending with Fy25 at 11 green Bar

Risk-Adjusted Returns: Why Sharpe Ratio and Sortino Ratio Are the Secret Weapons Smart Indian Investors Use to Measure True Portfolio Performance — Stop Chasing Raw Returns and Start Measuring What Really Matters

📅 Published April 04, 2026 (Saturday) The Biggest Mistake Indian Investors Make: Judging Performance by Raw Returns Alone Imagine two mutual fund managers. Manager A delivers […]

April 4, 2026

Bar Chart Showing Yearly Growth Fy20fy25 Fy25 is Green with Value 11 Other Years Reaching Up to 28 in Fy20

Cyclical vs Secular Growth: How Smart Indian Investors Tell Apart Temporary Booms from Permanent Wealth Creators

Learn how to distinguish cyclical growth from secular growth in Indian stocks — a critical skill that separates wealth creators from wealth destroyers. With Titan Biotech (₹504) case study, real Indian examples, and a practical 4-test framework.

April 4, 2026

Title rights Issues Demystified with a Dark Blue Infographic Showing Yearly Bars Fy20fy25 Fy25 Bar is Green and Value 11

Rights Issues Demystified: The Complete Indian Investor’s Guide — Should You Subscribe, Sell Your Rights, or Let Them Lapse?

FY 2025-26 has seen 120+ rights issues raising ₹39,439 crore — a 95% jump. Every Indian investor WILL face a rights issue. Should you subscribe, sell your RE shares, or let them lapse? This complete guide explains how to evaluate any rights issue using a 5-point framework, with real Indian market examples.